chr17-19661229-GCT-CC
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000176643.11(ALDH3A2):c.901_903delGCTinsCC(p.Ala301fs) variant causes a frameshift, missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A301P) has been classified as Uncertain significance. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000176643.11 frameshift, missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALDH3A2 | NM_000382.3 | c.901_903delGCTinsCC | p.Ala301fs | frameshift_variant, missense_variant | 6/10 | ENST00000176643.11 | NP_000373.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALDH3A2 | ENST00000176643.11 | c.901_903delGCTinsCC | p.Ala301fs | frameshift_variant, missense_variant | 6/10 | 1 | NM_000382.3 | ENSP00000176643.6 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Sjögren-Larsson syndrome Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 26, 2021 | Variant summary: ALDH3A2 c.901_903delinsCC (p.Ala301ProfsX13) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 282830 control chromosomes. c.901_903delinsCC has been reported in the literature with a legacy nomenclature of c.901G>C and c.906delT in individuals affected with Sjogren-Larsson Syndrome (example, Sillen_1998, Keller_2010). These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in 10%-<30% of normal fatty aldehyde dehydrogenase enzyme activity in patient fibroblasts (example, Keller_2010). One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. One laboratory classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Likely pathogenic, criteria provided, single submitter | literature only | Counsyl | Feb 19, 2015 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at